FDA Class II Recall: Progressa Bed Surfaces, intended to be used to… by Baxter Healthcare Corporation — Recall Details

Key facts

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Progressa Bed Surfaces, intended to be used to treat or prevent pulmonary or other complications associated with immobility, Product Codes P7520A19, P7520A20S, P7520A21, P7520A22S, P7520A23, P7520A24S, P7520A3, P7520A31, P7520A37, P7520A39, P7520A45, and P7520A4S. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Baxter Healthcare Corporation. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Baxter Healthcare Corporation should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Baxter Healthcare Corporation directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

Baxter Healthcare Corporation’s FDA history

Argus HQ has recorded 208 total FDA actions tied to Baxter Healthcare Corporation: 0 warning letters, 208 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

What is the FDA recall number for this event?

FDA recall number Z-1468-2025.

What is the current status of this recall?

Status as recorded by FDA: Ongoing.

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Is Progressa Bed Surfaces, intended to be used to treat or prev recalled?

Yes. FDA lists a Class II recall by Baxter Healthcare Corporation for Progressa Bed Surfaces, intended to be used to treat or prevent pulmonary or other complications associated with immobility, Product Codes P7520A19, P7520A20S, P7520A21, P7520A22S, P7520A23, P7520A24S, P7520A3, P7520A31, P7520A37, P7520A39, P7520A45, and P7520A4S., reported 20250402, with status "Ongoing." FDA recall number: Z-1468-2025.

Related enforcement actions

• Recall: Baxter Healthcare Corporation — Class I recall: Hillrom VOLARA System P.CIRCUIT KIT (Single Patient Use Circuit), Model/Catalog… →
• Recall: Baxter Healthcare Corporation — Class I recall: Hillrom VOLARA System P.CIRCUIT 5KIT AC, (Single Patient Use Circuit), Model/Cat… →
• Recall: Baxter Healthcare Corporation — Class II recall: Adapter for Head Positioning, Model/Catalog Number: 1739994, when used in conjun… →
• Recall: Baxter Healthcare Corporation — Class I recall: Hillrom VOLARA P.CIRCUIT 5KIT (System Single Patient Use Circuit), Model/Catalog… →
• Recall: Baxter Healthcare Corporation — Class I recall: Hillrom VOLARA System P.CIRCUIT KIT AC (Single Patient Use Circuit), Model/Catal… →
• Recall: Baxter Healthcare Corporation — Class I recall: Blue Ventilator Adapter Module, single-patient use circuit, Product Code M07937.… →
• Recall: Baxter Healthcare Corporation — Class II recall: Brand Name: Welch Allyn, Inc. Product Name: Welch Allyn Spot Vision Screener VS… →
• Recall: Baxter Healthcare Corporation — Class II recall: Brand Name: Spectrum IQ Product Name: Infusion Pump Model/Catalog Number: 3570… →